Topiramate associated hypohidrosis and hyperthermia

Area of Science:

• Neurology
• Pediatric Epilepsy
• Pharmacovigilance

Background:

• Topiramate is an established antiepileptic medication for partial onset and refractory seizures.
• While generally well-tolerated in pediatric populations, potential adverse effects require monitoring.
• Hypohidrosis and hyperthermia are known, albeit uncommon, side effects associated with topiramate therapy.

Observation:

• This report details two pediatric cases of epilepsy treated with topiramate.
• Both patients exhibited the development of hypohidrosis and hyperthermia during their treatment course.
• These symptoms emerged during the administration of topiramate for seizure management.

Findings:

• The study identifies a correlation between topiramate use and the occurrence of hypohidrosis and hyperthermia in children.
• The observed adverse events suggest a need for increased clinical vigilance in pediatric patients on topiramate.
• This reinforces the importance of recognizing and managing these specific side effects.

Implications:

• Clinicians should be aware of the risk of hypohidrosis and hyperthermia when prescribing topiramate to children.
• Early recognition and management of these adverse effects are crucial for patient safety.
• Further research may be warranted to elucidate the mechanisms and prevalence of these side effects in pediatric populations.